Internal link TIDES USA Congress Annual meeting on Oligonucleotide and Peptide Therapeutics in Boston, MA, U.S. Add TIDES USA to calender Research May 09 2022 to 12 May
Internal link ProQR Top-line results Phase 1/2 trial of sepofarsen in LCA10 patients Webcast ProQR presents Positive Top-Line Results from the Phase 1/2 Study of Sepofarsen in LCA10 Patients. Add ProQR Top-line results Phase 1/2 trial of sepofarsen in LCA10 patients to calender Healthcare professionals Investor Patient Research Oct 10 2019 8:00 AM ET